NewAmsterdam Pharma Company N.V. Warrant (NAMSW) stock news · rev $22.5M
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) warrant listed on NASDAQ.
This NAMSW news page leads with what NewAmsterdam Pharma Company N.V. Warrant filed — not a scraped headline mill.
No cached 8-K sentence for NAMSW yet. We will not pad this page with generic market recap.
Latest reported NAMSW revenue for 2025-12-31 was $22.5M. Net income was -$203.8M. Revenue was down 50.6% from 2024-12-31 to 2025-12-31. NAMSW currently screens at market cap $1.29B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NAMSW stock page; for the tape open the quote page.
NAMSW stock news FAQ
What are NAMSW's latest revenue and net income?
Latest cached NewAmsterdam Pharma Company N.V. Warrant (NAMSW) revenue for Dec 31, 2025 was $22.5M. Net income was -$203.8M. Statements: https://lician.com/financials/namsw
How did NAMSW revenue change from the prior cached period?
Cached NewAmsterdam Pharma Company N.V. Warrant (NAMSW) revenue was down 50.6% from $45.6M (Dec 31, 2024) to $22.5M (Dec 31, 2025). Statements: https://lician.com/financials/namsw
What is NAMSW's market cap?
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) market cap is $1.29B on the latest cached fundamentals snapshot.
Where is NAMSW listed?
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) warrant is listed on NASDAQ.
Where is NAMSW stock news listed?
Cached stock news for NewAmsterdam Pharma Company N.V. Warrant (NAMSW) is listed at https://lician.com/news/namsw. Filings: https://lician.com/sec/namsw
Not investment advice.